EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparison of Oral Versus Intravenous Iron Therapy for The Treatment of Anemia in Patients with End-Stage Renal Disease. An Interventional Study at a Tertiary Care Setting, Nowshera

Muhammad Sulman, Nadeem Ahmed Sheikh, Umair Ali, Muhammad Tanveer Ahmed, Aizaz Anwar, Joverya Nadeem

Life and Science · 06.07.2026 · 7 (3) · 7

DOI: 10.37185/lns.1.1.1150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life and Science, online erschienen am 06.07.2026. Verfasst von Muhammad Sulman und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our research seeks to compare the efficacy and safety of 'oral' versus 'intravenous' iron therapy in treating anemia in patients suffering from end-stage renal disease (ESRD), with a focus on hemoglobin response and adverse effects profile.Study Design: An interventional study.Place and Duration of Study: This study was conducted at the Department of Nephrology, Pak Emirates Military Hospital (PEMH), Rawalpindi, Pakistan, and the Department of Medicine and Otorhinolaryngology (ENT), Combined Military Hospitals (CMH), Nowshera, Pakistan, from September 2024 to September 2025.

Methods

The study included 163 patients with end-stage renal disease (ESRD) and anemia, who received either oral iron (N=69) or intravenous iron (N=94) therapy. Group 1 received oral ferrous sulfate 200 mg elemental iron daily for 8 weeks, while Group 2 received intravenous iron sucrose 200 mg weekly for 5 weeks, totaling 1 g. Hemoglobin levels, iron stores, adverse reactions, and treatment costs were monitored over 6 weeks of therapy.

Results

Weekly intravenous iron therapy showed significantly greater increase in hemoglobin levels (2.87±1.11g/dL vs 1.60±1.26g/dL, P

Zitieren

APA

Sulman, M., Sheikh, N. A., Ali, U., Ahmed, M. T., Anwar, A., & Nadeem, J. (2026). Comparison of Oral Versus Intravenous Iron Therapy for The Treatment of Anemia in Patients with End-Stage Renal Disease. An Interventional Study at a Tertiary Care Setting, Nowshera. Life and Science, 7(3), 7. https://doi.org/10.37185/lns.1.1.1150

Vancouver

Sulman M, Sheikh NA, Ali U, Ahmed MT, Anwar A, Nadeem J. Comparison of Oral Versus Intravenous Iron Therapy for The Treatment of Anemia in Patients with End-Stage Renal Disease. An Interventional Study at a Tertiary Care Setting, Nowshera. Life and Science. 2026;7(3):7. doi:10.37185/lns.1.1.1150

BibTeX
@article{Sulman2026,
  author = {Sulman, Muhammad and Sheikh, Nadeem Ahmed and Ali, Umair and Ahmed, Muhammad Tanveer and Anwar, Aizaz and Nadeem, Joverya},
  title = {Comparison of Oral Versus Intravenous Iron Therapy for The Treatment of Anemia in Patients with End-Stage Renal Disease. An Interventional Study at a Tertiary Care Setting, Nowshera},
  journal = {Life and Science},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {7},
  doi = {10.37185/lns.1.1.1150}
}
Kostenlos starten →